Steven Carroll to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Steven Carroll has written about Xenograft Model Antitumor Assays.
Connection Strength
0.617
-
Orthotopic xenografting of human luciferase-tagged malignant peripheral nerve sheath tumor cells for in vivo testing of candidate therapeutic agents. J Vis Exp. 2011 Mar 07; (49).
Score: 0.365
-
Combinatorial therapy with tamoxifen and trifluoperazine effectively inhibits malignant peripheral nerve sheath tumor growth by targeting complementary signaling cascades. J Neuropathol Exp Neurol. 2014 Nov; 73(11):1078-90.
Score: 0.118
-
Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent manner. Neuro Oncol. 2011 Jan; 13(1):28-41.
Score: 0.089
-
Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal. Drug Deliv. 2020 Nov 26; 27(1):1729-1740.
Score: 0.045